Aviso Financial’s Novo Nordisk NVO Stock Holding History

Aviso Financial’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.53K	Sell	32 -776	-96%	-$33.3K	﹤0.01%	259
2026 Q1	$29.7K	Sell	808 -3,484	-81%	-$165K	﹤0.01%	260
2025 Q4	$218K	Sell	4,292 -25,309	-86%	-$1.29M	0.01%	215
2025 Q3	$1.64M	Sell	29,601 -8,221	-22%	-$481K	0.07%	117
2025 Q2	$2.61M	Buy	37,822 +702	+2%	+$47.8K	0.12%	89
2025 Q1	$2.58M	Buy	37,120 +3,253	+10%	+$269K	0.13%	85
2024 Q4	$2.91M	Buy	33,867 +908	+3%	+$98.2K	0.15%	79
2024 Q3	$3.92M	Buy	32,959 +2,923	+10%	+$390K	0.19%	67
2024 Q2	$4.29M	Buy	+30,036	New	+$3.98M	0.24%	58

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Aviso Financial's NVO Position: Q2 2026 in Review

Aviso Financial reduced its Novo Nordisk (NVO) stake by 96% in Q2 2026, selling an estimated $33.3K and leaving 32 shares worth $1.53K. The position accounts for ﹤0.01% of the portfolio, ranked #259.

Aviso Financial first reported a position in NVO in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.29M in Q2 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Aviso Financial held 32 shares of Novo Nordisk worth $1.53K as of Q2 2026.
Aviso Financial sold 776 Novo Nordisk shares in Q2 2026, an estimated $33.3K.
Novo Nordisk made up ﹤0.01% of Aviso Financial's portfolio in Q2 2026, its #259 holding.
Aviso Financial first reported a position in Novo Nordisk in Q2 2024 and has held it in 9 quarters since.
Aviso Financial's Novo Nordisk position peaked at $4.29M in Q2 2024.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Aviso Financial's 13F filing for Q2 2026, filed 13 Aug 2026.